Jenkins Annalisa
Insider CIK 1639481 · ARDX Director · ONCS Director · SKYE Director · DMTX President and CEO, Director · AVRO Director · AGE Director · MREO Director · CMPS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SKYE Skye Bioscience, Inc. | A Award deriv | 2026-03-31 | 2026-04-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-26 | 2026-02-27 | 106,848 | — | $0 | 106,848 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2026-02-06 | 2026-02-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2025-06-12 | 2025-06-13 | 26,000 | — | $0 | 26,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 35,000 | — | $0 | 35,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2025-02-05 | 2025-02-06 | 15,243 | — | $0 | 15,243 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2024-10-28 | 2024-10-30 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2024-08-01 | 2024-08-05 | 161 | $6.88 | $1.1K | 19,480 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2024-05-09 | 2024-05-13 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2024-05-01 | 2024-05-03 | 211 | $8.48 | $1.8K | 19,641 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2024-02-08 | 2024-02-09 | 14,947 | — | $0 | 14,947 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2024-02-01 | 2024-02-05 | 175 | $11.34 | $2.0K | 19,852 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2023-11-01 | 2023-11-02 | 143 | $5.78 | $827 | 20,027 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2023-08-01 | 2023-08-03 | 161 | $8.95 | $1.4K | 20,170 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,643 | — | $0 | 17,643 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2023-06-02 | 2023-06-06 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2023-05-02 | 2023-05-04 | 25 | $7.97 | $199 | 20,331 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2022-06-16 | 2022-06-17 | 17,000 | — | $0 | 17,000 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| CMPS COMPASS Pathways plc | S Sale | 2022-03-29 | 2022-03-31 | 3,384 | $12.48 | $42.2K | 20,356 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2021-06-21 | 2021-06-23 | 65,000 | — | $0 | 65,000 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 17,438 | — | $0 | 17,438 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2019-06-13 | 2019-06-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2019-06-13 | 2019-06-17 | 20,072 | — | $0 | 33,471 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 9,675 | — | $0 | 9,675 | SEC↗ |
| AGE AgeX Therapeutics, Inc. | A Award deriv | 2019-03-11 | 2019-03-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2018-06-13 | 2018-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2018-06-13 | 2018-06-15 | 13,399 | — | $0 | 13,399 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 192,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 74,375 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 342,113 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 160,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 150,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 481,696 | — | $0 | 0 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2017-09-05 | 2017-09-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2017-07-03 | 2017-07-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2017-06-07 | 2017-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2017-02-01 | 2017-02-03 | 192,000 | — | $0 | 192,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2016-02-01 | 2016-02-02 | 160,000 | — | $0 | 160,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2015-04-20 | 2015-04-21 | 25,000 | — | $0 | 25,000 | SEC↗ |